Politics1 min read

STAT+: MAHA leader Calley Means castigates White House officials as bending to industry

By · Via STAT Health · Published by Everything Blog

In short

Calley Means, who recently served inside the White House and federal health agencies, voiced these frustrations during an appearance on Joe Rogan's podcast. He detailed how outside corporate interests have successfully pressured senior officials to alter planned administration policies. Specifically, Means disclosed that an official ordered an increase in the production of glyphosate despite health concerns raised by movement advocates. This directive was explicitly delivered as a non-negotiable decision following intense lobbying from industry organizations.

Key points

  • Leadership within the Make America Healthy Again movement claims their federal agenda is…: Leadership within the Make America Healthy Again movement claims their federal agenda is being derailed by corporate money.
  • Senior White House staff are reportedly yielding to external lobbying by adopting industr…: Senior White House staff are reportedly yielding to external lobbying by adopting industry-friendly policies over health reforms.
  • Internal conflicts over agricultural chemicals like glyphosate highlight deep policy divi…: Internal conflicts over agricultural chemicals like glyphosate highlight deep policy divisions between movement leaders and executive officials.

Sources checked by our analysis pipeline: 1

WASHINGTON — The Trump administration’s MAHA agenda has been derailed by corporate interests and the influence of money, a recently departed administration official told the podcaster Joe Rogan in a recording released Friday.

Calley Means, a key Make America Healthy Again leader who until recently worked in the White House and highest levels of the federal health agencies, said top White House officials were altering policies in response to industry influence and funding.

Means pointed to the fight over glyphosate, an herbicide many MAHA advocates argued causes grave health consequences. He recounted an “almost violent reaction” from industry groups that pressured agencies against researching or restricting the substance. He said a White House official later presented Means with a policy to boost its production — noting it was “not up for discussion.”

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Politics